You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / LAURUS LABS

LAURUS LABS
Intrinsic Value | Fundamental Analysis

Returns | 1W : -2.3% , 1M : 10.1%,1Y : 439%
BOM : 540222     NSE : LAURUSLABS    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
May 18,2021
Price(EOD): Rs. 480.25
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 25,770.22 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
LAURUS LABS -2.3% 10.1% 439%
SUN PHARMACEUTICAL INDUSTRIES -2.4% 9.2% 50.7%
DR REDDYS LABORATORIES -1.5% 7.7% 40.7%
DIVIS LABORATORIES -1.9% 5.7% 70.9%
CIPLA -0.7% -3.3% 54.7%
BIOCON -0.7% -4.8% 15%
AUROBINDO PHARMA -2.5% 9.9% 50.5%
LUPIN -0.9% 13.1% 37.8%
TORRENT PHARMACEUTICALS 0.3% 6.1% 14.8%


FUNDAMENTAL ANALYSIS OF LAURUS LABS

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than LAURUS LABS Premium


VALUATION OF LAURUS LABS

 
Valuation Score
Ratio Standalone
P/E
P/B
P/S
19.23
P/E Calculated based on EPS of 24.98
[ Mar2020 - Standalone Results ]

2.84
P/B Calculated based on Book Value of 169.4
[ Mar2020 - Standalone Results ]

7.99
P/S Calculated based on Revenues of 3226.48 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than LAURUS LABS Premium


FAIR VALUE OF LAURUS LABS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
217%
192%
253%

SHARE PRICE MOMENTUM OF LAURUS LABS

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.57
0.64
0.63
0.61
0.6
0.67
0.66
0.64
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
1.15 %
As on : Mar2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
9.94%
11.5%
11.06%
9.67%
68.68%
139.85%
207.39%
160.18%
QtrlyTrend
8
Latest Qtr: Mar2021

LAURUS LABS related INDICES

BSE Indices1W1M1Y
S&P BSE 250 LARGEMIDCAP 1.6% 4.6% 66.7%
S&P BSE 500 1.6% 4.9% 69.2%
S&P BSE ALLCAP 1.5% 5.2% 70.6%
S&P BSE MIDSMALLCAP 1.2% 8.3% 96.1%
S&P BSE 400 MIDSMALLCAP 1.1% 7.9% 96.3%
S&P BSE 150 MIDCAP 1.1% 7% 88.6%
S&P BSE SMALL CAP 1.1% 9.9% 110.7%
S&P BSE SMALLCAP SELECT INDEX 1% 7.1% 93.6%
S&P BSE HEALTHCARE -1.6% 6.9% 59.5%
NSE Indices1W1M1Y
NIFTY 200 1.6% 4.5% 65.3%
NIFTY 500 1.6% 4.9% 68.6%
NIFTY MIDCAP150 1.2% 6.8% 88.3%
NIFTY FREE MIDCAP 100 1.2% 7.4% 90.6%
NIFTY MID SMALL400 1.1% 8% 97.4%

FAQ [Frequently Asked Questions]


Is LAURUSLABS good for long term investment?

As on 18-May-2021, the Fundamentals of LAURUSLABS are Strong and hence it's good for long term investment! See Financial Performance of LAURUS LABS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is LAURUSLABS UnderValued or OverValued?

As on 18-May-2021, LAURUSLABS is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of LAURUSLABS ?

As on 18-May-2021, the Intrinsic Value of LAURUSLABS is Rs. 151.61 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 151.61
Fair Value [Median EV / Sales Model] : Rs. 164.30
Fair Value [Median Price / Sales Model] : Rs. 136.19
Median Fair Value of LAURUSLABS : Rs. 151.61

Is LAURUSLABS trading at a Premium or Discount?

As on 18-May-2021, LAURUSLABS is trading at a Premium of 217% based on the Median Intrinsic Value!

Is it right time to buy LAURUSLABS shares?

As on 18-May-2021, LAURUSLABS is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of LAURUSLABS?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with LAURUSLABS?

LAURUS LABS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
LAURUS LABS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
LAURUS LABS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
LAURUS LABS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
LAURUS LABS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
LAURUS LABS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
LAURUS LABS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
LAURUS LABS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
LAURUS LABS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z